Investigating the Landscape of C6-Azaindole Side Chain on the Epoxymorphinan Skeleton via the Nitrogen Walk Concept: A Strategy to Enhance Drug-Like Properties
Open Access
- 22 January 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (3) , 2330-2348
Abstract
Opioid use disorder (OUD) affects 2.1 million people in the U.S., and current treatments have significant limitations. Therefore, there is a critical need for novel, selective, potent, and reversible mu opioid receptor (MOR) antagonists for OUD treatment. The "message-address" concept applied to the naltrexone skeleton keeps the epoxymorphinan core (message) consistent while modifying the C-6 substituent (address). This approach led to the development of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN). In this study, we have designed and evaluated NAN analogues to enhance their pharmacological properties by applying the "nitrogen-walk" concept, i.e., replacing each CH group with a nitrogen atom on the indole ring sequentially while exploring different attachment positions onto the azaindole ring. A total of 36 analogues were synthesized and characterized. Competitive binding assays and functional activity studies identified eight potential MOR antagonists, with compound 7 showing the highest potency in a mouse antinociception model and inducing fewer withdrawal symptoms than naloxone.Keywords
Funding Information
- National Institute on Drug Abuse (UG3DA054785)
- National Institute on Drug Abuse (UH3DA050311)
This publication has 44 references indexed in Scilit:
- Molecular mechanisms of morphine tolerance and dependence; novel insights and future perspectivesMolecular and Cellular Biochemistry, 2023
- Impact of the COVID-19 Pandemic on Opioid Overdose Deaths: a Spatiotemporal AnalysisJournal of Urban Health, 2022
- The Opioid Epidemic During the COVID-19 PandemicJAMA, 2020
- Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulatorsJournal of Computer-Aided Molecular Design, 2020
- Current Understanding of the Neurobiology of Opioid Use Disorder: an OverviewCurrent Behavioral Neuroscience Reports, 2019
- Equipotent enantiomers of cyclic opioid peptides at μ opioid receptorPeptide Science, 2018
- Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulationBioorganic & Medicinal Chemistry, 2017
- Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligandsBioorganic & Medicinal Chemistry, 2015
- Plasma protein binding: From discovery to developmentJournal of Pharmaceutical Sciences, 2013
- On The Rate and Extent of Drug Delivery to the BrainPharmaceutical Research, 2007